These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2324420)

  • 1. Ketotifen and systemic mastocytosis.
    Ting S
    J Allergy Clin Immunol; 1990 Apr; 85(4):818. PubMed ID: 2324420
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of systemic mastocytosis; therapeutic efficacy of ketotifen.
    Póvoa P; Ducla-Soares J; Fernandes A; Palma-Carlos AG
    J Intern Med; 1991 May; 229(5):475-7. PubMed ID: 2040876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.
    Mallet AI; Norris P; Rendell NB; Wong E; Greaves MW
    Br J Clin Pharmacol; 1989 Jan; 27(1):88-91. PubMed ID: 2495814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis.
    Kettelhut BV; Berkebile C; Bradley D; Metcalfe DD
    J Allergy Clin Immunol; 1989 May; 83(5):866-70. PubMed ID: 2654254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive attacks due to systemic mastocytosis.
    François B; Duprez D; Oomen C; Kint A; Clement DL
    Acta Clin Belg; 1987; 42(1):53-7. PubMed ID: 3591218
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketotifen in systemic mastocytosis--a response.
    Kettelhut BV
    J Allergy Clin Immunol; 1991 Feb; 87(2):599. PubMed ID: 1993820
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
    Asawa A; Simpson KH; Bonds RS
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):443-6. PubMed ID: 25868710
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of systemic mastocytosis with flushing, palpitation and dyspnea].
    Kawano Y; Abe H; Yoshida K; Saitoh F; Kuramochi M; Ito K; Omae T
    Nihon Naika Gakkai Zasshi; 1987 Dec; 76(12):1883-4. PubMed ID: 3450776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Two cases of malignant and benign systemic mastocytosis].
    Mezei P; Bencsik Z; Vicze B; Simon K; István L; Pajor L
    Orv Hetil; 1999 Oct; 140(41):2297-300. PubMed ID: 10603744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
    Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
    de las Nieves M; Poveda F; Queipo de Llano MP; González-Hermoso C
    Sangre (Barc); 1997 Oct; 42(5):430-1. PubMed ID: 9424749
    [No Abstract]   [Full Text] [Related]  

  • 13. [Benign systemic mastocytosis: report of 2 cases].
    Velloso ED; Beitler B; Chamone DA
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):94-8. PubMed ID: 1843375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous mastocytosis as a rare differential diagnosis for unilateral chronic facial pain and erythema: a case report.
    Troeltzsch M; Berndt R; Woodlock T; Messlinger K; Troeltzsch M
    J Orofac Pain; 2013; 27(4):367-71. PubMed ID: 24171187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of zaditen in the treatment of mastocytosis in children].
    Kasimov N
    Vestn Dermatol Venerol; 1985 Oct; (10):52-4. PubMed ID: 3909688
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration.
    Olgun N; Oren H; Oren B; Irken G; Polat M; Cevik N
    Dermatology; 1993; 187(2):127-9. PubMed ID: 8358101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diffuse cutaneous urticarial mastocytosis. A 5-year course].
    Menni S; Piccinno R; Carminati G
    G Ital Dermatol Venereol; 1986; 121(5):351-3. PubMed ID: 3793146
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic mast cell disease: a rare cause of osteoporosis.
    Cacace E; Salis G; Ruggiero V; Perpignano G
    Clin Exp Rheumatol; 2006; 24(2):210. PubMed ID: 16762162
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketotifen in the treatment of atopic dermatitis. Results of a double blind study.
    Falk ES
    Riv Eur Sci Med Farmacol; 1993; 15(2):63-6. PubMed ID: 8171216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ketotifen in the prophylaxis of seasonal allergic asthma.
    Tinkelman DG; Webb CS; Vanderpool GE; Carroll MS; Spangler DL; Lotner GZ
    Ann Allergy; 1986 Mar; 56(3):213-7. PubMed ID: 3513669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.